In our Eye On Health this evening, we begin with a stunning realization about the popular anti-clogging drug Plavix. It's a drug designed to help prevent heart attacks, but it may actually be increasing the risk in some people.
The Food and Drug Administration says Plavix cannot be metabolized by patients with a certain genetic variation - putting them at greater risk for heart attack and stroke.
Patients can determine if they are "poor metabolizers'' by taking a simple genetic test.
The FDA will add its strongest warning to the Plavix label.
A new report says race plays a major role in the onset of Alzheimer's Disease.
The study found African Americans are twice as likely to develop the disease as whites. Hispanics, moreover, are one and a half times more likely.
Over 5 million Americans are currently living with Alzheimer's.
Finally, Botox is not just for wrinkles any more.
Now FDA has approved it to treat adults suffering from spasms of the elbow, wrist or fingers, common in those who have suffered a stroke or suffer from multiple sclerosis.
The FDA stresses that Botox should not be used to treat spasms in larger muscles in the legs and arms.
Researchers are also currently studying Botox to treat a variety of ailments including migraines.